Found 9693 bookmarks
Newest
FMT Trial Shows Limited Efficacy for C difficile Recurrences
FMT Trial Shows Limited Efficacy for C difficile Recurrences
Study halted due to ineffective results, but the findings still provide valuable insights for future research and improve treatment strategies for those affected by CDI.
·contagionlive.com·
FMT Trial Shows Limited Efficacy for C difficile Recurrences
Why Are Superbugs So Dangerous?
Why Are Superbugs So Dangerous?
Hello, it's Ashleigh coming to you from New York this week where the city is flooded with world leaders for the UN General Assembly. On Thursday the buzz of attention shifted to the “silent pandemic” of antimicrobial resistance. But first...
·bloomberg.com·
Why Are Superbugs So Dangerous?
Publisher Correction: Virulence factors, antibiotic susceptibility and sequence type distribution of hospital-associated Clostridioides difficile isolates in Israel, 2020-2022 - PubMed
Publisher Correction: Virulence factors, antibiotic susceptibility and sequence type distribution of hospital-associated Clostridioides difficile isolates in Israel, 2020-2022 - PubMed
Publisher Correction: Virulence factors, antibiotic susceptibility and sequence type distribution of hospital-associated Clostridioides difficile isolates in Israel, 2020-2022
·pubmed.ncbi.nlm.nih.gov·
Publisher Correction: Virulence factors, antibiotic susceptibility and sequence type distribution of hospital-associated Clostridioides difficile isolates in Israel, 2020-2022 - PubMed
Clostridioides difficile Infections in Children: What Is the Optimal Laboratory Diagnostic Method? - PubMed
Clostridioides difficile Infections in Children: What Is the Optimal Laboratory Diagnostic Method? - PubMed
The diagnosis of Clostridioides difficile infection (CDI) in the pediatric population is complicated by the high prevalence of asymptomatic colonization, particularly in infants. Many laboratory diagnostic methods are available, but there continues to be controversy over the optimal laborator …
·pubmed.ncbi.nlm.nih.gov·
Clostridioides difficile Infections in Children: What Is the Optimal Laboratory Diagnostic Method? - PubMed
Efficacy and safety of a preventive strategy against tuberculosis in liver transplantation recipients including the treatment of latent infection with moxifloxacin - PubMed
Efficacy and safety of a preventive strategy against tuberculosis in liver transplantation recipients including the treatment of latent infection with moxifloxacin - PubMed
A preventive strategy based on systematic LTBI screening and moxifloxacin treatment before LT in positive cases appears safe and effective in preventing the development of tuberculosis in LT recipients. However, our findings are limited by a small sample size; thus, larger studies are required to va …
·pubmed.ncbi.nlm.nih.gov·
Efficacy and safety of a preventive strategy against tuberculosis in liver transplantation recipients including the treatment of latent infection with moxifloxacin - PubMed
Which trials do we need? Fidaxomicin plus either intravenous metronidazole or tigecycline versus vancomycin plus either intravenous metronidazole or tigecycline for fulminant Clostridioides difficile infection - PubMed
Which trials do we need? Fidaxomicin plus either intravenous metronidazole or tigecycline versus vancomycin plus either intravenous metronidazole or tigecycline for fulminant Clostridioides difficile infection - PubMed
Which trials do we need? Fidaxomicin plus either intravenous metronidazole or tigecycline versus vancomycin plus either intravenous metronidazole or tigecycline for fulminant Clostridioides difficile infection
·pubmed.ncbi.nlm.nih.gov·
Which trials do we need? Fidaxomicin plus either intravenous metronidazole or tigecycline versus vancomycin plus either intravenous metronidazole or tigecycline for fulminant Clostridioides difficile infection - PubMed
Incubation period of Clostridioides difficile infection in hospitalized patients and long-term care facility residents: a prospective cohort study - PubMed
Incubation period of Clostridioides difficile infection in hospitalized patients and long-term care facility residents: a prospective cohort study - PubMed
Our findings are consistent with the previous studies that suggested the incubation period for CDI is typically less than 1 week and is less than 2 weeks in most cases.
·pubmed.ncbi.nlm.nih.gov·
Incubation period of Clostridioides difficile infection in hospitalized patients and long-term care facility residents: a prospective cohort study - PubMed
'Does this fecal microbiota transplant work?' Quality assurance of capsule based fecal microbiota transplant production - PubMed
'Does this fecal microbiota transplant work?' Quality assurance of capsule based fecal microbiota transplant production - PubMed
The fact that our caFMT compared similarly to the imported caFMT was viewed as a success in terms of quality assurance. Our caFMT had a slightly lower success rates compared to data from other studies, but could be affected by several other factors than our FMT-production methods. A lower success ra …
·pubmed.ncbi.nlm.nih.gov·
'Does this fecal microbiota transplant work?' Quality assurance of capsule based fecal microbiota transplant production - PubMed
Lateral flow immunoassay for simultaneous detection of C. difficile, MRSA, and K. pneumoniae - PubMed
Lateral flow immunoassay for simultaneous detection of C. difficile, MRSA, and K. pneumoniae - PubMed
Mainly performed within a rapid diagnostic tests company, a lateral flow (LF) system using gold nanoparticles (AuNPs) as transducers is presented able to detect three bacteria of interest, of relevance for antimicrobial resistance (AMR): Clostridioides difficile, methicillin-resistant Staphylococcus …
·pubmed.ncbi.nlm.nih.gov·
Lateral flow immunoassay for simultaneous detection of C. difficile, MRSA, and K. pneumoniae - PubMed
Gut Microbial and Metabolic Features Associated With Clostridioides difficile Infection Recurrence in Children - PubMed
Gut Microbial and Metabolic Features Associated With Clostridioides difficile Infection Recurrence in Children - PubMed
Our study suggests that the differing gut microbiota profiles in pediatric CDI patients may contribute to disease recurrence by modulating SCFA concentrations and bile acid profiles. The gut microbiota and metabolite signatures may be used to predict disease recurrence in children with CDI.
·pubmed.ncbi.nlm.nih.gov·
Gut Microbial and Metabolic Features Associated With Clostridioides difficile Infection Recurrence in Children - PubMed
Fecal microbiota spores, live-brpk (VOWST™/VOS) for prevention of recurrent Clostridioides difficile infection - PubMed
Fecal microbiota spores, live-brpk (VOWST™/VOS) for prevention of recurrent Clostridioides difficile infection - PubMed
Clostridioides difficile infection (CDI) is a health crisis comprising a majority of healthcare-associated infections and is now being seen in the community. Persistent dysbiosis despite treatment with standard-of-care antibiotics increases risk of recurrent infections. Fecal microbiota trans …
·pubmed.ncbi.nlm.nih.gov·
Fecal microbiota spores, live-brpk (VOWST™/VOS) for prevention of recurrent Clostridioides difficile infection - PubMed
Advocating for Better Regulatory Rules and Standard of Care for C difficile
Advocating for Better Regulatory Rules and Standard of Care for C difficile
Maryann Webb’s harrowing, personal experience with C diff, along with her professional work with federal agencies has prepared her for a life in advocacy with the Peggy Lillis Foundation. She wants to see the fecal microbiota transplant become more accessible and is working with Congress to make the infection a notifiable infectious disease.
·contagionlive.com·
Advocating for Better Regulatory Rules and Standard of Care for C difficile
Identification and preclinical evaluation of MMV676558 as a promising therapeutic candidate against Clostridioides difficile - PubMed
Identification and preclinical evaluation of MMV676558 as a promising therapeutic candidate against Clostridioides difficile - PubMed
Clostridioides difficile, a gram-positive, toxin-producing, spore-forming anaerobe, is a major cause of antibiotic-associated diarrhoea. The bacterium's intrinsic drug resistance limits current treatment options to fidaxomicin and vancomycin for initial episodes, with anti-toxin B monoclonal antibod …
·pubmed.ncbi.nlm.nih.gov·
Identification and preclinical evaluation of MMV676558 as a promising therapeutic candidate against Clostridioides difficile - PubMed
Rational Design of Live Biotherapeutic Products for the Prevention of Clostridioides difficile Infection - PubMed
Rational Design of Live Biotherapeutic Products for the Prevention of Clostridioides difficile Infection - PubMed
Clostridioides difficile infection (CDI) is a major cause of healthcare- and antibiotic-associated diarrhea. While fecal microbiota transplantation (FMT) shows promise for recurrent CDI, its mechanisms and long-term safety are not fully understood. Live biotherapeutic products (LBPs) using pre-defin …
·pubmed.ncbi.nlm.nih.gov·
Rational Design of Live Biotherapeutic Products for the Prevention of Clostridioides difficile Infection - PubMed
Clostridium Difficile Infections Market to Expand Significantly by 2034, States DelveInsight | Crestone, Inc, ImmuniMed Inc., Ferring Pharmaceuticals, Deinove, Lumen Bioscience, Inc., Vedanta Biosciences, Inc., Hospices Civils de Lyon
Clostridium Difficile Infections Market to Expand Significantly by 2034, States DelveInsight | Crestone, Inc, ImmuniMed Inc., Ferring Pharmaceuticals, Deinove, Lumen Bioscience, Inc., Vedanta Biosciences, Inc., Hospices Civils de Lyon
The Clostridium Difficile Infections market is expected to surge due to the disease s increasing prevalence and awareness during the forecast period Furthermore launching various multiple stage Clostridium Difficile Infections pipeline products will significantly revolutionize the Clostridium Difficile Infections market ...
·openpr.com·
Clostridium Difficile Infections Market to Expand Significantly by 2034, States DelveInsight | Crestone, Inc, ImmuniMed Inc., Ferring Pharmaceuticals, Deinove, Lumen Bioscience, Inc., Vedanta Biosciences, Inc., Hospices Civils de Lyon
[Molecular characteristics and antibiotic resistance of Clostridioides difficile isolated from children in China] - PubMed
[Molecular characteristics and antibiotic resistance of Clostridioides difficile isolated from children in China] - PubMed
Objective: To understand molecular characteristics and antibiotic resistance of Clostridioides (C.) difficile isolated from children in China, and provide data support the development of disease risk assessment and burden studies. Methods: A total of 155 strains of …
·pubmed.ncbi.nlm.nih.gov·
[Molecular characteristics and antibiotic resistance of Clostridioides difficile isolated from children in China] - PubMed
Comparison of toxin gene expression levels and molecular typing of Clostridioides difficile strains isolated from patients with diarrhea - PubMed
Comparison of toxin gene expression levels and molecular typing of Clostridioides difficile strains isolated from patients with diarrhea - PubMed
We encountered toxigenic C. difficile strains with various toxin expression levels, ribotypes, and rep types based on the findings of this study. This indicated that various clones from various sources circulate in the hospitals and among patients.
·pubmed.ncbi.nlm.nih.gov·
Comparison of toxin gene expression levels and molecular typing of Clostridioides difficile strains isolated from patients with diarrhea - PubMed
Understanding the Symbiotic Relationship of Biofilms and Vancomycin
Understanding the Symbiotic Relationship of Biofilms and Vancomycin
A new study looked at Bacteroides thetaiotaomicron and C difficile infection (CDI) and their formation of symbiotic biofilms in the antibiotic's environment, and underscore the complexity of CDI prevention and the importance of considering gut microbiomes in treatment strategies.
·contagionlive.com·
Understanding the Symbiotic Relationship of Biofilms and Vancomycin
Infections following chimeric antigen receptor T cell therapy: 2018-2022 - PubMed
Infections following chimeric antigen receptor T cell therapy: 2018-2022 - PubMed
COVID-19 and C. difficile infection were the most common infections following CAR T-cell therapy. Most infections occurred within the first 100 days. Empiric antibiotic use and C. difficile infection were common in patients with CRS/ICANS, in the absence of documented bacterial infection, thus provi …
·pubmed.ncbi.nlm.nih.gov·
Infections following chimeric antigen receptor T cell therapy: 2018-2022 - PubMed
Genomic epidemiology of Clostridioides difficile Sequence Type 35 reveals intraspecies and interspecies clonal transmission - PubMed
Genomic epidemiology of Clostridioides difficile Sequence Type 35 reveals intraspecies and interspecies clonal transmission - PubMed
Clostridioides difficile sequence type (ST) 35 has been found in humans and animals worldwide. However, its genomic epidemiology and clonal transmission have not been explored in detail. In this study, 176 C. difficile ST35 isolates from six countries were sequenced. Genomic diversity, …
·pubmed.ncbi.nlm.nih.gov·
Genomic epidemiology of Clostridioides difficile Sequence Type 35 reveals intraspecies and interspecies clonal transmission - PubMed
Intestinal microbiota and high-risk antibiotic resistance genes in wild birds with varied ecological traits: Insights from opportunistic direct sampling in Tianjin, China - PubMed
Intestinal microbiota and high-risk antibiotic resistance genes in wild birds with varied ecological traits: Insights from opportunistic direct sampling in Tianjin, China - PubMed
Within One Health framework, the dissemination of antibiotic resistance genes (ARGs) and pathogenic bacteria by wild birds has attracted increasing attention. In this study, gut samples of wild birds opportunistically collected in Tianjin, China, situated along the East Asian-Australasian Flyway, we …
·pubmed.ncbi.nlm.nih.gov·
Intestinal microbiota and high-risk antibiotic resistance genes in wild birds with varied ecological traits: Insights from opportunistic direct sampling in Tianjin, China - PubMed